• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型含4-酰基吡唑啉酮衍生物和辅助配体的铜(II)配合物诱导肝癌细胞凋亡

Novel Copper(II) Complex with a 4-Acylpyrazolone Derivative and Coligand Induce Apoptosis in Liver Cancer Cells.

作者信息

Nurmamat Marhaba, Yan Haili, Wang Ru, Zhao Huixin, Li Yanhong, Wang Xiaojing, Nurmaimaiti Kaidirye, Kurmanjiang Tamasha, Luo Difang, Baodi Jumagul, Xu Guancheng, Li Jinyu

机构信息

College of Life Sciences, Xinjiang Normal University, Urumqi 830054, China.

Institute of Applied Chemistry, College of Chemistry, Xinjiang University, Urumqi 830046, China.

出版信息

ACS Med Chem Lett. 2021 Feb 26;12(3):467-476. doi: 10.1021/acsmedchemlett.0c00680. eCollection 2021 Mar 11.

DOI:10.1021/acsmedchemlett.0c00680
PMID:33738074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7957940/
Abstract

A novel pyrazolone-based copper complex [CuL(phen)(CHOH)][CuL(phen)]·CHCHOH·CHOH (P-FAH-Cu-phen) was synthesized and characterized. The asymmetric structural unit of P-FAH-Cu-phen was composed of two independent complex units [CuL(phen)(CHOH)] and [CuL(phen)]:Cu1 center with six coordination mode and Cu2 center with five coordination mode. The growth of BEL-7404 cells and H22 cells was significantly inhibited by P-FAH-Cu-phen with IC values of 1.175 μg/mL and 1.097 μg/mL, respectively, which were much lower than IC of cisplatin for BEL-7404 cells (23.32 μg/mL) and H22 cells (27.5 μg/mL). P-FAH-Cu-phen induced cell cycle arrest at G2/M and apoptosis in BEL-7404 cells through mitochondria- and endoplasmic reticulum stress-associated pathways. Moreover, P-FAH-Cu-phen significantly suppressed the migration of BEL-7404 cells and the tumor growth in H22 tumor mouse model without severe side effects and improved the survival of tumor mice. The results suggested that P-FAH-Cu-phen might be a potential drug candidate for the treatment of live cancer.

摘要

合成并表征了一种新型的基于吡唑啉酮的铜配合物[CuL(phen)(CHOH)][CuL(phen)]·CHCHOH·CHOH(P-FAH-Cu-phen)。P-FAH-Cu-phen的不对称结构单元由两个独立的配合物单元[CuL(phen)(CHOH)]和[CuL(phen)]组成:具有六配位模式的Cu1中心和具有五配位模式的Cu2中心。P-FAH-Cu-phen对BEL-7404细胞和H22细胞的生长具有显著抑制作用,IC值分别为1.175μg/mL和1.097μg/mL,远低于顺铂对BEL-7404细胞(23.32μg/mL)和H22细胞(27.5μg/mL)的IC值。P-FAH-Cu-phen通过线粒体和内质网应激相关途径诱导BEL-7404细胞的细胞周期阻滞于G2/M期并引发凋亡。此外,P-FAH-Cu-phen在H22肿瘤小鼠模型中显著抑制BEL-7404细胞的迁移和肿瘤生长,且无严重副作用,并提高了肿瘤小鼠的存活率。结果表明,P-FAH-Cu-phen可能是一种治疗肝癌的潜在候选药物。

相似文献

1
Novel Copper(II) Complex with a 4-Acylpyrazolone Derivative and Coligand Induce Apoptosis in Liver Cancer Cells.新型含4-酰基吡唑啉酮衍生物和辅助配体的铜(II)配合物诱导肝癌细胞凋亡
ACS Med Chem Lett. 2021 Feb 26;12(3):467-476. doi: 10.1021/acsmedchemlett.0c00680. eCollection 2021 Mar 11.
2
Probing the cell death signaling pathway of HepG2 cell line induced by copper-1,10-phenanthroline complex.探究铜-1,10-菲啰啉配合物诱导的HepG2细胞系的细胞死亡信号通路。
Biometals. 2014 Jun;27(3):445-58. doi: 10.1007/s10534-014-9710-2. Epub 2014 Mar 18.
3
Dinuclear copper(II) complexes with {Cu2(mu-hydroxo)bis(mu-carboxylato)}+ cores and their reactions with sugar phosphate esters: A substrate binding model of fructose-1,6-bisphosphatase.具有{Cu2(μ-羟基)双(μ-羧基)}+核心的双核铜(II)配合物及其与磷酸糖酯的反应:果糖-1,6-二磷酸酶的底物结合模型
Inorg Chem. 2006 Apr 3;45(7):2925-41. doi: 10.1021/ic051942d.
4
Efficient hydrolytic cleavage of DNA and antiproliferative effect on human cancer cells by two dinuclear Cu(II) complexes containing a carbohydrazone ligand and 1,10-phenanthroline as a coligand.两种双核 Cu(II) 配合物通过包含碳酰腙配体和 1,10-邻菲啰啉作为共配体,对 DNA 的高效水解断裂作用以及对人癌细胞的抗增殖作用。
J Biol Inorg Chem. 2019 May;24(3):343-363. doi: 10.1007/s00775-019-01651-8. Epub 2019 Mar 18.
5
Synthesis and antitumor mechanisms of a copper(II) complex of anthracene-9-imidazoline hydrazone (9-AIH).蒽-9-咪唑啉腙(9-AIH)铜(II)配合物的合成及其抗肿瘤机制
Metallomics. 2015 Jul;7(7):1124-36. doi: 10.1039/c5mt00027k.
6
Dinuclear Cu(I) complexes of pyridyl-diazadiphosphetidines and aminobis(phosphonite) ligands: synthesis, structural studies and antiproliferative activity towards human cervical, colon carcinoma and breast cancer cells.吡啶基二氮杂二磷杂环丁烷和氨基双(亚磷酸酯)配体的双核铜(I)配合物:合成、结构研究及其对人宫颈癌、结肠癌和乳腺癌细胞的抗增殖活性
Dalton Trans. 2014 Aug 7;43(29):11339-51. doi: 10.1039/c4dt00832d. Epub 2014 Jun 12.
7
Chemodynamic therapy agents Cu(II) complexes of quinoline derivatives induced ER stress and mitochondria-mediated apoptosis in SK-OV-3 cells.喹啉衍生物的 Cu(II) 配合物作为化学动力学治疗剂诱导 SK-OV-3 细胞发生内质网应激和线粒体介导的细胞凋亡。
Eur J Med Chem. 2021 Nov 5;223:113636. doi: 10.1016/j.ejmech.2021.113636. Epub 2021 Jun 16.
8
Facile synthesis of a new Cu(ii) complex with an unsymmetrical ligand and its use as an O donor metalloligand in the synthesis of Cu(ii)-Mn(ii) complexes: structures, magnetic properties, and catalytic oxidase activities.一种新型不对称配体 Cu(ii)配合物的简便合成及其作为 O 供体金属配体在合成 Cu(ii)-Mn(ii)配合物中的应用:结构、磁性和催化氧化酶活性。
Dalton Trans. 2020 Jan 28;49(4):1276-1291. doi: 10.1039/c9dt04315b. Epub 2020 Jan 7.
9
Synthesis, structural characterization and cytotoxic activity of ternary copper(II)-dipeptide-phenanthroline complexes. A step towards the development of new copper compounds for the treatment of cancer.三元铜(II)-二肽-菲咯啉配合物的合成、结构表征及细胞毒性活性。迈向开发用于治疗癌症的新型铜化合物的一步。
J Inorg Biochem. 2014 Oct;139:117-23. doi: 10.1016/j.jinorgbio.2014.06.007. Epub 2014 Jun 17.
10
Polyoxometalate-supported transition metal complexes and their charge complementarity: synthesis and characterization of [M(OH)6Mo6O18[Cu(Phen)(H2O)2]2][M(OH)6Mo6O18[Cu(Phen)(H2O)Cl]2].5H2O (M = Al(+, Cr3+).多金属氧酸盐负载的过渡金属配合物及其电荷互补性:[M(OH)6Mo6O18[Cu(Phen)(H2O)2]2][M(OH)6Mo6O18[Cu(Phen)(H2O)Cl]2].5H2O(M = Al(+)、Cr3+)的合成与表征
Inorg Chem. 2005 Nov 28;44(24):8846-54. doi: 10.1021/ic050830j.

引用本文的文献

1
Copper pyrithione, a copper complex ATG4B and autophagy inhibitor, exhibits potent anticancer effects.吡啶硫酮铜,一种铜络合物,是ATG4B和自噬抑制剂,具有强大的抗癌作用。
Acta Pharmacol Sin. 2025 Jul 28. doi: 10.1038/s41401-025-01619-2.
2
Mechanisms of Copper-Induced Autophagy and Links with Human Diseases.铜诱导自噬的机制及其与人类疾病的联系
Pharmaceuticals (Basel). 2025 Jan 15;18(1):99. doi: 10.3390/ph18010099.
3
Cuproptosis: mechanisms and links with cancers.铜死亡:机制与癌症的关联。
Mol Cancer. 2023 Mar 7;22(1):46. doi: 10.1186/s12943-023-01732-y.
4
Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.铜死亡相关特征可预测肝细胞癌的预后、肿瘤微环境和药物敏感性。
J Immunol Res. 2022 Nov 16;2022:3393027. doi: 10.1155/2022/3393027. eCollection 2022.

本文引用的文献

1
Endoplasmic reticulum stress-induced apoptosis in the development of reproduction.内质网应激诱导的细胞凋亡在生殖发育中的作用
Reprod Contracept. 2016 Mar;27(1):51-59. doi: 10.7669/j.issn.1001-7844.2016.01.0051. Epub 2016 May 4.
2
Cold-inducible protein RBM3 mediates hypothermic neuroprotection against neurotoxin rotenone via inhibition on MAPK signalling.冷诱导蛋白 RBM3 通过抑制 MAPK 信号通路介导低温对神经毒素鱼藤酮的神经保护作用。
J Cell Mol Med. 2019 Oct;23(10):7010-7020. doi: 10.1111/jcmm.14588. Epub 2019 Aug 22.
3
Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma.晚期肝细胞癌系统治疗的药物遗传学。
World J Gastroenterol. 2019 Aug 7;25(29):3870-3896. doi: 10.3748/wjg.v25.i29.3870.
4
Clinical immunology and immunotherapy for hepatocellular carcinoma: current progress and challenges.肝细胞癌的临床免疫学和免疫治疗:当前进展和挑战。
Hepatol Int. 2019 Sep;13(5):521-533. doi: 10.1007/s12072-019-09967-y. Epub 2019 Jul 27.
5
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
6
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
7
Synthesis and Pharmacological Activities of Pyrazole Derivatives: A Review.吡唑衍生物的合成及药理活性研究进展。
Molecules. 2018 Jan 12;23(1):134. doi: 10.3390/molecules23010134.
8
Apoptosis signaling and BCL-2 pathways provide opportunities for novel targeted therapeutic strategies in hematologic malignances.凋亡信号和 BCL-2 通路为血液恶性肿瘤的新型靶向治疗策略提供了机会。
Blood Rev. 2018 Jan;32(1):8-28. doi: 10.1016/j.blre.2017.08.004. Epub 2017 Aug 8.
9
Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.铂、钯、金和钌配合物作为抗癌剂:当前临床应用、细胞毒性研究及未来展望。
Eur J Med Chem. 2017 Dec 15;142:8-31. doi: 10.1016/j.ejmech.2017.04.007. Epub 2017 Apr 18.
10
Novel copper complexes as potential proteasome inhibitors for cancer treatment (Review).新型铜配合物作为癌症治疗的潜在蛋白酶体抑制剂(综述)
Mol Med Rep. 2017 Jan;15(1):3-11. doi: 10.3892/mmr.2016.6022. Epub 2016 Dec 9.